Long-term effects of proximal small bowel exclusion by duodenal-jejunal bypass liner on weight reduction and glycemic control in diabetic patients

Obesity and type 2 diabetes (T2D) have become a substantial burden on public health in the last century, and different strategies to mitigate them are advocated [1]. Proximal small bowel diversion bears prominent beneficial metabolic effects associated with augmentation of the incretin system and accelerated glucose handling in the distal part of the gut [2,3]. Roux-en-Y gastric bypass surgery exhibits these advantages [4 –6] and is an effective tool for weight reduction and glycemic control [7].

Source: Surgery for Obesity and Related Diseases - July 28, 2018 Category: Surgery Authors: Liat Deutsch, Limor Ben-Haim, Yael Sofer, Nathan Gluck, Erwin Santo, Sigal Fishman Tags: Original article Source Type: research